Dawn Lee

Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Anthony J. Hatswell, Becky Pennington, L. Pericleous et al. · Health and Quality of Life Outcomes · 2014 · 42 citations · Full text

The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam®) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When Trial Evidence is Limited

Dawn Lee, Daniel Gladwell, A. Batty et al. · Pediatric Drugs · 2013 · 35 citations

Trial Evidence, Pediatric Neurosurgery, Oromucosal Midazolam +5

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

Dawn Lee, Koo Wilson, Ron Akehurst et al. · Heart · 2014 · 31 citations · Full text

The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England

Yang Meng, N. Hertel, J. Ellis et al. · The European Journal of Health Economics · 2018 · 30 citations · Full text

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

Dawn Lee, Patrick Thornton, Alexander Hirst et al. · Applied Health Economics and Health Policy · 2013 · 27 citations · Full text